Phthalide Treatment for Selective Stem Cell Removal

The patent applies parameter changes by utilizing differential sensitivity to chemical compounds. Differentiated cells are treated with compounds (such as 5-azacytidine or other chemotherapeutic agents) to which they are sensitive, causing their death, while undifferentiated pluripotent stem cells are resistant to these compounds and survive. This chemical parameter-based separation eliminates the need for time-consuming flow cytometry sorting while maintaining safety by selectively removing differentiated cells rather than relying on surface antigen sorting that may alter cell properties.

The patent replaces the mechanical and technical complexity of flow cytometry sorting systems with a simple chemical treatment approach. Instead of using sophisticated instrumentation, lasers, and automated sorting mechanisms, the method employs chemical compounds that can be added directly to cell cultures. This substitution dramatically simplifies the manufacturing process, reduces costs, and eliminates the need for specialized equipment and highly trained personnel while achieving the same safety objective of reducing residual undifferentiated cells.

The patent applies local quality by creating different chemical sensitivity profiles for differentiated versus undifferentiated cells. Through the use of specific chemotherapeutic agents like 5-azacytidine, the method targets differentiated cells with high selectivity due to their specific metabolic and cellular characteristics. This localized chemical action ensures that only differentiated cells are affected while undifferentiated pluripotent stem cells remain unaffected, achieving high measurement precision in cell type differentiation and removal selectivity that surpasses the non-specific effects of quercetin treatment.